Atlas Trials

Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety

Clinical trial NCT05504486 · WITHDRAWN

Trial details

NCT number
NCT05504486
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Major Depressive Disorder (MDD)
Start date
2022-08-29
Primary completion
2023-03-22
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.